An RSV vaccine already used for older adults could help protect people as young as 18 who are at increased risk of the disease, drugmaker Pfizer said.
An RSV vaccine already used for older adults could help protect people as young as 18 who are at increased risk of the disease, drugmaker Pfizer said.
Pfizer plans to file for an expanded approval of Abrysvo, which is currently approved for adults ages 60 and above and expectant mothers.
It is part of a “wider" programme to “ensure the most vulnerable and marginalised" are protected against serious disease and illness
In a concerted effort to combat misinformation and promote vaccine uptake across Ghana, the National Media Vaccine Network has been officially launched in Accra. Spearheaded by the Executive Secretary of the African Media and Malaria Network (AMMEREN), Dr Charity Binka, along with Dr Emmanuel Addipa-Adapoe and a dedicated team, this initiative marks a significant step […]
Key takeaways: Participants in Nigeria have been vaccinated with a Lassa
Pfizer And A Corruption Too Deep To Fix Authored by Jeffrey Tucker via The Epoch Times, Old movies and new ones often turn on the theme of corruption. For generations, viewers have enjoyed discovering the ins and outs of a gang of people who are up to no good, financially and otherwise. It’s always a shock to see the way the insiders treat each other so brutally, and how they lie, cheat, and steal to get their way. It’s especially satisfying when they get caught in the end. ...
Fugitive pastor Apollo Quiboloy is hiding in his vast compound in Tamayong, Davao City, according to former president Rodrigo Duterte.
The pharma giant previously received billions in federal funding and raked in huge profits, but owes nothing in 2023 income taxes thanks to legal loopholes and Trump-era tax cuts.
A shortage of pertussis or whooping cough vaccines is expected next month and an order for additional doses will be placed, according to the Department of Health.
Xylazine is an FDA-approved sedative and pain reliever for use in animals, but it has severe adverse effects when used in humans. It is now illicitly being added to opioids,
Pfizer's Own Study Confirms Paxlovid Sucks A Pfizer-funded, peer-reviewed paper authored by Pfizer scientists reveals that the company's antiviral COVID medication Paxlovid completely sucks, confirming what everyone's known since it came out. In a randomized phase 2-3 trial of the drug conducted between Aug. 25, 2021 through July 25, 2022, 654 out of 1,296 patients were dosed with at least one 300mg dose of Paxlovid + 100mg of protease inhibitor ritonavir vs. a placebo group. The...